论文部分内容阅读
目的:探讨小儿房性心动过速药物治疗效果。方法:总结2008年1月至2014年11月我院收治的小儿房性心动过速患儿46例,分析其药物治疗特点、疗效及随访情况。结果:46例房性心动过速患儿,男30例,女16例,年龄1个月~11岁,平均(36.75±3.50)个月。41例患儿进行了6个月~4年随访,平均随访时间(2.85±1.05)年,有5例失访。所有患儿给予抗心律失常药物治疗,均有效转复心律,其中30例给予胺碘酮转复,10例应用普罗帕酮转复,5例应用胺碘酮+美托洛尔成功转复,1例给予三磷酸腺苷(ATP)转复,治疗成功率100%,无死亡病例。结论:胺碘酮治疗小儿房性心动过速效果明显,特别对于婴幼儿持续性房性心动过速,具有较好疗效,38例患儿随访提示小儿房性心动过速可能为自限性疾病。
Objective: To investigate the therapeutic effect of drug on atrial tachycardia in children. Methods: A total of 46 children with atrial tachycardia admitted to our hospital from January 2008 to November 2014 were analyzed. The characteristics, efficacy and follow-up of the drug treatment were analyzed. Results: 46 cases of atrial tachycardia, 30 males and 16 females, aged 1 months to 11 years old, with an average (36.75 ± 3.50) months. 41 cases of children were followed up for 6 months to 4 years, the average follow-up time (2.85 ± 1.05) years, 5 cases were lost. All children given anti-arrhythmic drug therapy, are effective in the rehabilitation of heart rhythm, 30 cases were given amiodarone to restore, 10 cases were treated with propafenone, 5 cases of amiodarone + metoprolol successful rehabilitation, One case was given adenosine triphosphate (ATP), the success rate of 100%, no deaths. Conclusion: Amiodarone is effective in treating atrial tachycardia in children, especially for persistent atrial tachycardia in infants and toddlers. Follow-up in 38 children suggests that atrial tachycardia in children may be a self-limiting disease .